Patients should not assume that MHRA approval automatically translates to immediate NHS availability in any part of the UK
Healthy nutrition will aid in your weight loss and in your overall health
The retatrutide peptide represents a new frontier in metabolic science, not only for obesity but also for insulin resistance, fatty liver disease, cardiovascular risk, and type 2 diabetes complications
As summarized in Table S1, the level of evidence is still low, derived mainly from in vitro studies, animal models, and small patient cohorts, with only limited data from RCT available
This happens because GLPs improve satiety, insulin-sensitivity and can decrease food noise, in the brain
Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive Resmetirom exhibits promising results as a specific treatment for MASH